ANVS

Annovis Bio Inc

Jun 04 • 11:39AM ET

1.93

+0.08 4.59 %

Healthcare • Biotechnology • USA • Micro • NYSE

Peers: ANIX ATYR COYA CYPH EXOZ FBIO ICCC INO MCRB XBIT

| Held by: VTI VXF DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.72	Insider Own	13.70%	Shs Outstand	34.65M	Perf Week	1.84%
Market Cap	67.05M	Forward P/E	-	EPS next Y	-1.55	Insider Trans	21.35%	Shs Float	29.90M	Perf Month	-14.76%
Enterprise Value	52.83M	PEG	-	EPS next Q	-0.46	Inst Own	16.52%	Short Float	15.63%	Perf Quarter	-21.98%
Income	-40.92M	P/S	-	EPS this Y	-32.86%	Inst Trans	1.97%	Short Ratio	4.50	Perf Half Y	-56.12%
Sales	0.00M	P/B	17.66	EPS next Y	16.40%	ROA	-190.43%	Short Interest	4.67M	Perf YTD	-44.08%
Book/sh	0.11	P/C	4.71	EPS next 5Y	-10.42%	ROE	-301.13%	52W High	5.50 -64.82%	Perf Year	-40.28%
Cash/sh	0.41	P/FCF	-	EPS past 3/5Y	23.23% -10.15%	ROIC	-1309.11%	52W Low	1.54 25.59%	Perf 3Y	-85.40%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.59% 8.07%	Perf 5Y	-96.98%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	20.55%	Oper. Margin	-	ATR (14)	0.16	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	45.74	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.27	EPS Q/Q	-99.06%	SMA20	-6.49%	Beta	1.19	Target Price	12.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.23%	Rel Volume	2.28	Prev Close	1.85
Employees	8	LT Debt/Eq	0.00	Earnings	May 15 BMO	SMA200	-25.48%	Avg Volume	1.04M	Price	1.93
IPO	Jan 29, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-59.49% -	Trades		Volume	860,361	Change	4.59%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)